Dr. Reddy's Laboratories
RDY
#1764
Rank
A$16.42 B
Marketcap
A$19.73
Share price
-1.55%
Change (1 day)
-4.17%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): A$1.34 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.95 Billion. a decrease over its 2024 earnings that were of A$1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$1.23 B-2.73%
2024 A$1.26 B7.01%
2023 A$1.18 B17.62%
2022 A$1.00 B43.27%
2021 A$0.70 B31.44%
2020 A$0.53 B54.54%
2019 A$0.34 B-14.21%
2018 A$0.40 B26.15%
2017 A$0.31 B4.69%
2016 A$0.30 B-55.7%
2015 A$0.68 B1.83%
2014 A$0.67 B-3.78%
2013 A$0.70 B54.07%
2012 A$0.45 B-16.23%
2011 A$0.54 B56.66%
2010 A$0.34 B-235.36%
2009 -A$0.26 Billion-198.53%
2008 A$0.26 B30.77%
2007 A$0.19 B-14.61%
2006 A$0.23 B703.63%
2005 A$29.09 M649.45%
2004 A$3.88 M-95.68%
2003 A$89.76 M-14.86%
2002 A$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.09 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.73 B 1,257.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.85 B 941.98%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$13.16 B 967.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$3.03 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel